
Obesity drug sparks competition in America
Danish pharmaceutical company Novo Nordisk announced on Monday the launch of its weight-loss pills, “Wegovi,” in the United States, in a move considered the most significant in the obesity drug market, which is witnessing fierce competition among…
Read more